Nurix Therapeutics
NRIX
NRIX
139 hedge funds and large institutions have $721M invested in Nurix Therapeutics in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 41 increasing their positions, 45 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 45
1.07% less ownership
Funds ownership: 101.47% → 100.4% (-1.1%)
Holders
139
Holding in Top 10
–
Calls
$564K
Puts
$335K
Top Buyers
| 1 | +$26.6M | |
| 2 | +$18M | |
| 3 | +$14.6M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$14.3M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$4.41M |
Top Sellers
| 1 | -$55M | |
| 2 | -$22.2M | |
| 3 | -$10.2M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$8.23M |
| 5 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$7.41M |